INTERNATIONAL ANESTHESIA RESEARCH SOCIETY
Mission Statement
The IARS mission is to encourage, stimulate, and fund ongoing anesthesia-related research projects that will enhance and advance the specialty, and to disseminate current, state-of-the art, basic and clinical research data in all areas of clinical anesthesia, including perioperative medicine, critical care, and pain management. The IARS is focused solely on the advancement and support of education and scientific research related to anesthesiology. To fulfill this mission the Society publishes a monthly scientific journal, Anesthesia & Analgesia, conducts an annual clinical and scientific meeting, funds anesthesia-related research, and sponsors the SmartTots research initiative.
Financial Overview — FY 2024
Compared with Peers
FY 2024| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
63.9% | 83.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
36.1% | 10.7% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
58.1 mo | 12.8 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
19.1% | 10.1% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
70.8% | 90.7% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
18.3% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-8.5% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
14.1% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $6.9M | $5.9M | $28.5M | 63.9% | 12 |
| 2023 | $5.8M | $6.4M | $25.7M | 67.6% | 11 |
| 2022 | $6.1M | $6.2M | $23.6M | 66.8% | 12 |
| 2021 | $7.6M | $6.2M | N/A | — | 12 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.